CE Certified Sensor Solutions for Oncology & Continuous Monitoring
Precision wrist-worn bio-sensors engineered for real-time cardiotoxicity tracking, vital sign monitoring, and remote clinical trial compliance across Finland and the Nordic region.
- Single-Lead ECG & PPG Array
- IP68 Submersible Waterproofing
- Continuous SpO2 & Temperature
- Zero-Distraction Screenless Design
- Extended 15-Day Battery Endurance
- Raw Bio-Signal SDK Access
- Standalone Direct 4G Data Sync
- Integrated GPS & Fall Detection
- Real-Time Arrhythmia Alerts
- Medical Grade Stainless Electrodes
- Ultra-Lightweight Ergonomic Form
- High Compliance Trial Design
- Continuous Skin Temp Monitoring
- Multi-Wavelength Optical PPG
- Automated Sleep & Activity Staging
- High-Precision Heart Rate & ECG
- iOS & Android Gateway Compatibility
- Remote Tele-health Monitoring
- 15 Days Continuous Runtime
- 3ATM Hydro-Sealed Enclosure
- SpO2 & Continuous Pedometer
- Patient Identification NFC Module
- Continuous Blood Pressure Trend
- Clinical Trial Protocol Ready
Decentralized Oncology Clinical Trials (DCT) in Finland: The Wearable Paradigm
Modern oncology drug development is undergoing a rapid structural transition toward Decentralized Clinical Trials (DCT) and hybrid monitoring frameworks. In Finland, where the healthcare ecosystem is anchored by world-class research institutes such as the HUS Comprehensive Cancer Center (Helsinki University Hospital), Tampere University Hospital (TAUH), and Oulu University Hospital (OYS), the integration of continuous, medical-grade bio-sensor wearables has become indispensable. Cancer patients undergoing aggressive chemotherapy, targeted immunotherapy, or novel antibody-drug conjugate (ADC) therapies frequently experience systemic toxicity, transient febrile episodes, and severe fatigue between scheduled hospital visits.
Traditional clinical protocol relies heavily on episodic clinic visits—leaving multi-week observational blind spots. As a specialized OEM/ODM manufacturer and international exporter, our CE-certified wearable sensor platform bridges this monitoring gap. By capturing high-frequency physiological parameters—including single-lead ECG rhythm strips, optical photoplethysmography (PPG at up to 128 Hz), skin surface temperature, galvanic skin response (GSR), and pulse oximetry (SpO2)—our wrist-worn biosensors deliver complete longitudinal visibility into patient health status without imposing patient burden.
Key Benefits for Finnish Trial Sponsors & CROs:
- Early Detection of Neutropenic Fever: Continuous dermal temperature monitoring detects hyperthermic spikes hours before standard oral thermometry, enabling rapid anti-infective intervention in immunocompromised cancer subjects.
- Cardiotoxicity & QTc Prolongation Tracking: On-demand and continuous single-lead ECG recording allows biostatisticians to measure QTc interval alterations induced by targeted kinase inhibitors and oncology therapeutics.
- Objective Performance Status Metrics: Replaces subjective ECOG score surveys with objective 3-axis accelerometer kinetic data, tracking true ambulatory activity and resting circadian sleep fragmentation.
Engineered for Clinical Research Rigor
Our medical wearables are built from the ground up for medical device regulatory compliance, seamless cloud integration, and comfortable long-term wear in extreme environmental conditions.
CE MDR & ISO 13485 Certified
Manufactured under strict ISO 13485 quality systems. Fully compliant with EU Medical Device Regulation (EU-MDR 2017/745) Class IIa/IIb standards, ensuring seamless ethics board approvals across Finland and Europe.
Unrestricted Raw Data Access (128Hz)
No vendor lock-in or proprietary data obfuscation. Researchers receive full IP-free export of raw 128 Hz optical PPG waveforms, micro-volt ECG traces, and accelerometer vectors via REST API or Mobile SDKs.
Nordic Climate Adaptability
Engineered for sub-zero thermal stability down to -20°C. Advanced optical PPG gain adjustment compensating for peripheral vasoconstriction caused by harsh Finnish winter climates.
EU GDPR & HIPAA Compliant Security
End-to-end AES-256 encrypted telemetry transmission with local EU data residency option. Purpose-built for integration with Finland's Kanta health archive and national MyData frameworks.
Screenless Design for Maximum Adherence
Eliminates patient distraction and anxiety by removing interactive screens. Ensures zero accidental touch inputs while extending continuous battery performance up to 15 days on a single magnetic USB charge.
EMR & eCOA System Interoperability
Directly interfaces with Epic Hyperspace, Cerner, and Finnish regional healthcare EHR systems via HL7 FHIR protocols. Seamlessly couples biometric streams with electronic patient-reported outcomes (eCOA).
Adapting Bio-Sensors to Finland’s Wellbeing Services Counties (Hyvinvointialueet)
Finland’s recent structural social and healthcare reform introduced 21 Wellbeing Services Counties (hyvinvointialueet), alongside the City of Helsinki and HUS Group, tasked with streamlining clinical pathways and lowering care delivery costs. In this modernized framework, remote monitoring wearables serve as an essential technological bridge connecting tertiary cancer centers with home-based palliative and active treatment monitoring.
When deploying medical wearables across Finland, factory exporters must satisfy stringent localized criteria. Our production lines provide specialized hardware and firmware customizations explicitly optimized for Nordic requirements:
Localized Compliance & Engineering Features:
- Biobank & FinnGen Project Compatibility: Data pipelines support integration with Finland's rich biobank network (such as THL Biobank and Finnish Biobank Cooperative - FINBB), allowing combined genomic and continuous physiological data analysis.
- Sub-Zero Thermal Micro-Capacitor Design: Custom Li-po battery chemistry prevents rapid passive discharge in extreme sub-zero Finnish winters, guaranteeing stable voltage during outdoor patient movement.
- Biocompatible Hypoallergenic Silicones: ISO 10993 cytotoxicity and skin irritation certification, essential for oncological subjects experiencing skin sensitivity due to radiation therapy or epidermal growth factor receptor (EGFR) inhibitors.
Factory Direct B2B OEM/ODM Customization for International Exporters
As a vertically integrated manufacturer, we eliminate intermediary distributor markups, supplying Finnish trial sponsors, MedTech brands, and CRO contract research organizations directly from our ISO 13485 certified production facilities. Whether your project requires custom firmware for specialized arrhythmia detection algorithms, white-labeled mobile SDKs, or branded enclosure packaging, our engineering team provides end-to-end ODM support.
Custom ODM/OEM Services Include:
- Custom optical LED wavelength pairing (Green 525nm, Red 660nm, Infrared 940nm) for optimized dermal penetration across varied skin phototypes.
- NFC chip integration for tap-to-pair hospital ward assignment and patient ID verification.
- Automated early warning score (EWS) algorithm embedding directly into sensor MCU for offline edge computing alerts.
- Direct supply chain export logistics to Helsinki-Vantaa airport with complete customs compliance documentation under EU free-trade directives.
Frequently Asked Questions from Finnish Buyers & Researchers
Essential answers regarding CE MDR compliance, data governance, export logistics, and technical specifications for trial teams in Finland.